Activity

Activity ID

4722

Expires

October 1, 2023

Format Type

Enduring

CME Credit

1

Fee

$30
CME Provider

JAMA Otolaryngology – Head & Neck Surgery

Description

Leading COVID-19 vaccine candidates rely on new genetic technologies that have fast-tracked development and testing. This video explains the principles underlying the leading DNA, messenger RNA (mRNA), and viral vector vaccine candidates, and how they might induce immunity to SARS-CoV-2 infection.

Disclaimers
1. This activity is accredited by the American Medical Association.
2. This activity is free to AMA members.

Register for this Activity

ABMS Member Board Approvals by Type
More Information
Commercial Support?
No

NOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.

Educational Objectives

To understand how the newest genetic technologies are being utilized to develop a COVID-19 vaccine

Keywords

Clinical Challenge, Head and Neck Surgery, Hematology, Otolaryngology, Radiology

Competencies

Medical Knowledge

CME Credit Type

AMA PRA Category 1 Credit

Additional Information

doi: 10.1001/jama.2020.16951

View All Activities by this CME Provider

The information provided on this page is subject to change. Please refer to the CME Provider’s website to confirm the most current information.